Frequency-dependent electrophysiologic properties of ventricular repolarization in patients with congenital long QT syndrome

Journal of the American College of Cardiology

Volumn 28, Issue 5, 1996, Pages 1269-1277

  Hirao, Hidekazu ^a   Shimizu, Wataru ^a,b   Kurita, Takashi ^a   Suyama, Kazuhiro ^a   Aihara, Naohiko ^a   Kamakura, Shiro ^a   Shimomura, Katsuro ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b MASONIC MEDICAL RESEARCH LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN;

ADOLESCENT; ADRENERGIC ACTIVITY; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART MUSCLE POTENTIAL; HEART PACING; HEART RATE; HEART REPOLARIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LONG QT SYNDROME; MALE; PRIORITY JOURNAL;

ACTION POTENTIALS; ADOLESCENT; ADULT; CARDIAC PACING, ARTIFICIAL; CHILD; CHILD, PRESCHOOL; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; EPINEPHRINE; FEMALE; HEART RATE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; VENTRICULAR FUNCTION;

EID: 0030298223     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00313-0     Document Type: Article

References (35)

1. 1. Jervell A, Lange-Nielsen F. Congenital deaf mutism, prolonged QT interval, and sudden death. Am Heart J 1957;54:59-68.
2. 2. Romano C, Gemme G, Pongiglione R. Atitimie cardiache rare dell'eta periatrica: II. Accessi sincopali per fibrillazione ventricolare parossistica. Clin Pediatr (Bologna) 1963;45:656-61.
3. 3. Ward OC. New familial cardiac syndrome in children. J Ir Med Assoc 1964;54:103-6.
4. 4. Schwartz PJ, Locati E. The idiopathic long QT syndrome: pathogenetic mechanisms and therapy. Eur Heart J 1985;6 Suppl D:103-14.
5. 5. Schwartz PJ, Locati EH, Moss AJ, Crampton RS, Trazzi R, Ruberti U. Left cardiac sympathetic denervation in the therapy of the congenital long QT syndrome: a worldwide report. Circulation 1991;84:503-11.
6. 6. Moss A. Liu JE, Gottlieb S, Locati EH, Schwartz PJ, Robinson JL. Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome. Circulation 1991;84:1524-9.
7. 7. Eldar M, Griffin JC, Van Hare GF, et al. Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome. J Am Coll Cardiol 1992;20:830-7.
8. 8. Garza LA, Vick RL, Nora JJ, McNamara DG. Heritable Q-T prolongation without deafness. Circulation 1970;41;39-48.
9. 9. Shimizu W, Ohe T, Kurita T, Shimomura K. Differential response of QTU interval to exercise, isoproterenol, and atrial pacing in patients with congenital long QT syndrome. PACE 1991;14:1966-70.
10. 10. Curtiss EI, Heibel RH, Shaver JA. Autonomic maneuvers in hereditary Q-T interval prolongation (Romano-Ward syndrome). Am Heart J 1978;95: 420-8.
11. 11. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome: an update. Circulation 1993;88:782-4.
12. 12. Franz MR. Long-term recording of monophasic action potentials from human endocardium. Am J Cardiol 1983;52:1629-34.
13. 13. Franz MR, Swerdlow CD, Liem LB, Schaefer J. Cycle length dependence of human action potential duration in vivo: effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies. J Clin Invest 1988;82:972-9.
14. 14. Shimizu W, Ohe T, Kurita T, et al. Early afterdepolarizations induced by isoproterenol in patients with congenital long QT syndrome. Circulation 1991:84:1915-23.
15. 15. Shimizu W, Ohe T, Kurita T, Tokuda T, Shimomura K. Epinephrine-induced ventricular premature complexes due to early afterdepolarizations and effects of verapamil and propranolol in a patient with congenital long QT syndrome. J Cardiovasc Electrophysiol 1994;5:438-44.
16. 16. Shimizu W, Ohe T, Kurita T, et al. Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome. J Am Coll Cardiol 1995;26:1299-309.
17. 17. Greenhouse SW, Geisser A. On methods in analysis of profile data. Psychometrika 1959;24:95-112.
18. 18. Moss AJ. Prolonged QT-interval syndrome. JAMA 1986;256:2985-7.
19. 19. Bhandari AK, Shapiro WA, Morady F, Shen EN, Mason J, Scheinman MM. Electrophysiologic testing in patients with the long QT syndrome. Circulation 1985;71:63-71.
20. 20. Jackman WM, Friday KJ, Anderson JL, Aliot MC, Lazzara R. The long QT syndrome: a critical review, new clinical observation and a unifying hypothesis. Prog Cardiovasc Dis 1988;31:115-72.
21. 21. Keating M, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 1991;252:704-6.
22. 22. Jiang C, Atkinson D, Towbin JA, et al. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet 1994;8:141-7.
23. 23. Wang Q, Shen J, Splawski I, et al. SCN5A mutations cause an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80:805-11.
24. 24. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT, A molecular basis for cardiac arrhythmia: HERG mutation cause long QT syndrome. Cell 1995;80:795-803.
25. 25. Wang Q, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996;12:17-23.
26. 26. Sanguinetti MC, Jiang C Curran ME, Keating MT. A mechanistic link between an inherited and acquired cardiac arrhythmia: HERG encodes the Ikr potassium channel. Cell 1995;81:299-307.
27. 27. Moss AJ, Zareba W, Benhorin J, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995;92: 2929-34.
28. + current by defotilide. Circ Res 1993;72:75-83.
29. + channel blockade and to increases in heart rate: implications for gene-specific therapy. Circulation 1995;92:3381-6.
30. 30. Han J, Moe GK. Nonuniform recovery of excitability in ventricular muscle. Circ Res 1964;14:44-60.
31. 31. Kuo CS, Munakata K, Reddy CP, Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential duration. Circulation 1983;67:1356-67.
32. 32. Surawicz B. Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations? J Am Coll Cardiol 1989;14:172-84.
33. 33. Linker NJ, Colonna P, Kekwick CA, Till J, Camm AJ, Ward DE. Assessment of QT dispersion in symptomatic patients with congenital long QT syndrome. Am J Cardiol 1992;69:634-8.
34. 34. Priori SG, Napolitano C, Diehl L, Schwartz PJ. Dispersion of the QT interval: a marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 1994;89:1681-9.
35. 35. Shimizu W, Kamakura S, Ohe T, et al. Diagnostic value of recovery time measured by body surface mapping in patients with congenital long QT syndrome. Am J Cardiol 1994;74:780-5.